Medi Assist Healthcare has fixed Friday, September 11, 2026, as the record date to determine shareholder eligibility for its final dividend of ₹2 per equity share for the financial year ended March 31, 2026 (FY26). The Board of Directors recommended this payout during their meeting on May 09, 2026, and it remains subject to approval by shareholders at the company’s 26th Annual General Meeting (AGM). This dividend represents a direct return on capital for investors holding shares on the record date, contingent upon regulatory compliance and shareholder approval.

The 26th AGM is scheduled for Thursday, September 24, 2026, at 10:30 AM (IST), conducted via Video Conferencing or Other Audio-Visual Means in compliance with Ministry of Corporate Affairs and SEBI circulars. Upon approval at the AGM, the dividend will be remitted within 30 days through electronic payment modes to shareholders with registered bank account details. The company emphasized that dividend payments will strictly follow SEBI Master Circular No. SEBI/ HO/ MIRSD/ POD-1/ P/ CIR/ 2024/ 37 dated May 7, 2024, which mandates electronic payments only for physical shareholders who have updated their KYC details with the Registrar & Share Transfer Agent (RTA), MUFG Intime India Private Limited.

Dividend and Taxation Details

Shareholders must ensure their Permanent Account Number (PAN) is linked with Aadhaar to avoid higher tax deduction at source (TDS). Under Section 262 of the Income Tax Act, 2025, failure to link PAN with Aadhaar renders the PAN inoperative, triggering a TDS rate of 20% under Section 397. For resident individuals with valid PANs, TDS is deducted at 10% under Section 393(1) read with Section 393(4), unless they qualify for exemption under Form 121 or receive less than ₹10,000 in total dividends during FY 2026-27.

Non-resident shareholders are subject to withholding tax at 20% plus applicable surcharge and cess under Section 393(2) of the Act, unless they provide a certificate under Section 395 for lower/nil withholding or claim benefits under Double Tax Avoidance Agreements (DTAA). To avail DTAA benefits, non-residents must submit a Tax Residency Certificate, e-filed Form 41, and self-declarations by the cut-off date.

Shareholder Compliance Requirements

The company has set September 11, 2026, as the strict cut-off for submitting all tax-related documents, including Form 121, declarations under Rule 203 of the Income Tax Rules, 2026, and DTAA eligibility proofs. Documents must be uploaded via the RTA portal; email submissions will not be accepted. Intermediaries holding shares for beneficial owners must submit declarations under Rule 203 to ensure TDS credit is given to the actual beneficial owner. Failure to provide required documents may result in TDS being deducted at the highest applicable rate, though shareholders can claim refunds via their income tax returns if eligible. The company’s Company Secretary & Compliance Officer, Rashmi B V, signed the intimation on August 11, 2026.

Medi Assist Healthcare Services Ltd has initiated a structural change in its Board leadership by altering the designation of Dr. Vikram Jit Singh Chhatwal from Whole-Time Director to Non-Executive, Non-Independent Director, effective August 08, 2026. This transition, which takes effect at the close of business hours on that date, is designed to separate the roles of Chairman and executive management, thereby strengthening the company’s governance framework and succession planning. Consequently, Dr. Chhatwal will cease to be a Key Managerial Personnel of the company while continuing on the Board as Chairman liable to retire by rotation.

The Board of Directors approved the change based on the recommendation of the Nomination and Remuneration Committee. The decision was formalized during a Board meeting that commenced at 1:45 p.m. (IST) and concluded at 3:00 p.m. (IST) on August 08, 2026. The approval remains subject to the consent of the company’s members and any other regulatory approvals required under applicable laws.

Dr. Chhatwal, who holds DIN 01606329, brings extensive experience to his new role. He holds a Bachelor’s degree in Medicine and Surgery from Jawaharlal Nehru Medical College, a Doctor of Philosophy from the National University of Singapore, a Master’s Degree in Business Administration in International Management from École Nationale des Ponts et Chaussées, Paris, and a Post-Graduate Diploma in Public Health Administration from the Institute of Healthcare Administration, Chennai. Prior to joining Medi Assist, he served as CEO of Reliance Health and CEO of Apollo Health Street, part of the Apollo Hospitals Group.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The company confirmed that Dr. Chhatwal is not debarred from holding the office of Director pursuant to any SEBI Order or other statutory authority. There are no disclosed relationships between directors regarding this appointment.

Governance Implications

The separation of the Chairman and Chief Executive roles is a key corporate governance best practice aimed at enhancing board independence and oversight. By moving Dr. Chhatwal to a non-executive role, Medi Assist seeks to ensure clearer accountability structures while retaining his strategic guidance as Chairman. The change underscores the company’s commitment to aligning its leadership structure with global governance standards, particularly relevant given Dr. Chhatwal’s background in international healthcare management.